Clinical Trial Update: A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease; the trial is completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Coronary Artery Disease

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Asthma, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2010-12-15